Treatment of migraine headache with or without aura

Active Ingredient: Zolmitriptan

Indication for Zolmitriptan

Population group: only adults (18 - 65 years old)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

2.5-5 mg 1-2 times daily

For:

Dosage regimens

Regimen A: Oral, 2.5 milligrams zolmitriptan, 1 to 2 times daily. The maximum allowed total dose is 10 milligrams zolmitriptan daily.

Regimen B: Oral, 5 milligrams zolmitriptan, 1 to 2 times daily. The maximum allowed total dose is 10 milligrams zolmitriptan daily.

Detailed description

The recommended dose of zolmitriptan to treat a migraine attack is 2.5 mg. It is advisable that zolmitriptan is taken as early as possible after the onset of migraine headache but it is also effective if taken at a later stage.

If symptoms of migraine should recur within 24 hours following an initial response, a second dose may be taken. If a second dose is required, it should not be taken within 2 hours of the initial dose. If a patient does not respond to the first dose, it is unlikely that a second dose will be of benefit in the same attack.

If a patient does not achieve satisfactory relief with 2.5 mg doses, for subsequent attacks 5 mg doses of zolmitriptan could be considered.

The total daily intake should not exceed 10 mg. Not more than 2 doses of zolmitriptan should be taken in any 24 hour period.

Zolmitriptan is not indicated for prophylaxis of migraine.

5-10 mg daily

For:

Dosage regimens

Nasal, 5 milligrams zolmitriptan, 1 to 2 times daily. The maximum allowed total dose is 10 milligrams zolmitriptan daily.

Detailed description

The recommended dose of zolmitriptan to treat a migraine attack is 5 mg.

Zolmitriptan nasal spray is administered as a single dose into one nostril. Zolmitriptan provides particularly rapid onset of relief of migraine with the first signs of efficacy apparent within 15 minutes of dosing.

If symptoms persist or return within 24 hours a second dose has been shown to be effective. If a second dose is required, it should not be taken within 2 hours of the initial dose.

It is advisable that zolmitriptan is taken as early as possible after the onset of migraine headache.

In the event of recurrent attacks, it is recommended that the total intake of zolmitriptan in a 24 hour period should not exceed 10 mg.

Zolmitriptan is not indicated for prophylaxis of migraine.

Active ingredient

Zolmitriptan

Zolmitriptan has been demonstrated to be a selective agonist for the vascular human recombinant 5HT1B and 5HT1D receptor subtypes. Zolmitriptan is a high affinity 5HT1B/1D receptor agonist with modest affinity for 5HT1A receptors.

Read more about Zolmitriptan

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.